Attitude of Libyan Pharmacist In Western Regionof Libya Toward Zantac With drawal

Abstract

    Post-marketing drug withdrawals can be associated with various events, ranging from safety issues such as reported deaths or severe side-effects, to a multitude of non-safety problems including lack of efficacy, manufacturing, regulatory or business issues. During the last century, the majority of drugs voluntarily withdrawn from the market or prohibited by regulatory agencies was reported to be related to adverse drug reactions. Understanding the under lying mechanisms of toxicity is of utmost importance for current and future drug discovery. A questioner review about Libyan pharmacist attitude toward  Zantac withdrawal in the western region of Libya. Thedata then was evaluated by Microsoft Excel software for analysis. The total number of responses received was 67, and these responses were from different cities in the west of Libya during 6months study 2020. Highlighting the different sources of knowledge regarding the withdrawal decision,  64.1 % got the information through social media. 32.8 % of the pharmacists after getting the information regarding Ranitidine withdrawal  returned it to the company from which bought it. 83.6% of the pharmacist when asked about ranitidine cause of drawing clarified that the ranitidine contains carcinogenic substances. 37.3% of participants mentioned that pharmacovigilance means the detection of problems related to drugs after marketing and use by patients. The aim of this work is to know whether Libya really has drug control and how to deal with medicines that are withdrawn from the market by international organizations andto analyze the  know ledgeand attitudeof Libyan pharmacists in western region of Libya about Zantac withdrawn from the market. From  the results of a questionnaire conducted in the western regions about knowledge and attitude of Libyan pharmacists toward Zantac withdraw from the market, we concluded that a small percentage of Zantac products have been withdrawn and the doctors are still prescribing and pharmacists are dispensing ranitidine, whether it is OTC or POM.